Cargando…
8th International Conference: Primary Therapy of Early Breast Cancer, St Gallen, Switzerland, March 12–15 2003
The International St Gallen Breast Cancer Conference concentrates almost exclusively on adjuvant, multimodal primary therapy for early breast cancer. Begun 25 years ago, this meeting was initially held every 4 years, but therapeutic progress, new strategies and provocative trials data have accelerat...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC165020/ https://www.ncbi.nlm.nih.gov/pubmed/12817991 http://dx.doi.org/10.1186/bcr611 |
_version_ | 1782120818884476928 |
---|---|
author | Glen, Hilary Jones, Robert J |
author_facet | Glen, Hilary Jones, Robert J |
author_sort | Glen, Hilary |
collection | PubMed |
description | The International St Gallen Breast Cancer Conference concentrates almost exclusively on adjuvant, multimodal primary therapy for early breast cancer. Begun 25 years ago, this meeting was initially held every 4 years, but therapeutic progress, new strategies and provocative trials data have accelerated to the extent that conferences are now held biennially. The meeting this year was attended by almost 3000 delegates. Major topics included new prognostic and predictive markers in early breast cancer, the best use of adjuvant chemotherapy and endocrine therapy, and innovations in local surgery and radiation therapy. |
format | Text |
id | pubmed-165020 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2003 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-1650202003-07-12 8th International Conference: Primary Therapy of Early Breast Cancer, St Gallen, Switzerland, March 12–15 2003 Glen, Hilary Jones, Robert J Breast Cancer Res Meeting Report The International St Gallen Breast Cancer Conference concentrates almost exclusively on adjuvant, multimodal primary therapy for early breast cancer. Begun 25 years ago, this meeting was initially held every 4 years, but therapeutic progress, new strategies and provocative trials data have accelerated to the extent that conferences are now held biennially. The meeting this year was attended by almost 3000 delegates. Major topics included new prognostic and predictive markers in early breast cancer, the best use of adjuvant chemotherapy and endocrine therapy, and innovations in local surgery and radiation therapy. BioMed Central 2003 2003-05-30 /pmc/articles/PMC165020/ /pubmed/12817991 http://dx.doi.org/10.1186/bcr611 Text en Copyright © 2003 BioMed Central Ltd |
spellingShingle | Meeting Report Glen, Hilary Jones, Robert J 8th International Conference: Primary Therapy of Early Breast Cancer, St Gallen, Switzerland, March 12–15 2003 |
title | 8th International Conference: Primary Therapy of Early Breast Cancer, St Gallen, Switzerland, March 12–15 2003 |
title_full | 8th International Conference: Primary Therapy of Early Breast Cancer, St Gallen, Switzerland, March 12–15 2003 |
title_fullStr | 8th International Conference: Primary Therapy of Early Breast Cancer, St Gallen, Switzerland, March 12–15 2003 |
title_full_unstemmed | 8th International Conference: Primary Therapy of Early Breast Cancer, St Gallen, Switzerland, March 12–15 2003 |
title_short | 8th International Conference: Primary Therapy of Early Breast Cancer, St Gallen, Switzerland, March 12–15 2003 |
title_sort | 8th international conference: primary therapy of early breast cancer, st gallen, switzerland, march 12–15 2003 |
topic | Meeting Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC165020/ https://www.ncbi.nlm.nih.gov/pubmed/12817991 http://dx.doi.org/10.1186/bcr611 |
work_keys_str_mv | AT glenhilary 8thinternationalconferenceprimarytherapyofearlybreastcancerstgallenswitzerlandmarch12152003 AT jonesrobertj 8thinternationalconferenceprimarytherapyofearlybreastcancerstgallenswitzerlandmarch12152003 |